BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

678 related articles for article (PubMed ID: 19783988)

  • 1. Interleukin 10 acts on regulatory T cells to maintain expression of the transcription factor Foxp3 and suppressive function in mice with colitis.
    Murai M; Turovskaya O; Kim G; Madan R; Karp CL; Cheroutre H; Kronenberg M
    Nat Immunol; 2009 Nov; 10(11):1178-84. PubMed ID: 19783988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel Foxp3(-) IL-10(-) Regulatory T-cells Induced by B-Cells Alleviate Intestinal Inflammation in Vivo.
    Shao TY; Hsu LH; Chien CH; Chiang BL
    Sci Rep; 2016 Sep; 6():32415. PubMed ID: 27581189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The gut feeling of Treg cells: IL-10 is the silver lining during colitis.
    Unutmaz D; Pulendran B
    Nat Immunol; 2009 Nov; 10(11):1141-3. PubMed ID: 19841645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-4 inhibits TGF-beta-induced Foxp3+ T cells and, together with TGF-beta, generates IL-9+ IL-10+ Foxp3(-) effector T cells.
    Dardalhon V; Awasthi A; Kwon H; Galileos G; Gao W; Sobel RA; Mitsdoerffer M; Strom TB; Elyaman W; Ho IC; Khoury S; Oukka M; Kuchroo VK
    Nat Immunol; 2008 Dec; 9(12):1347-55. PubMed ID: 18997793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of Intestinal Inflammation With Epicutaneous Immunotherapy Requires TGF-β and IL-10 but Not Foxp3
    Chen X; Berin MC; Gillespie VL; Sampson HA; Dunkin D
    Front Immunol; 2021; 12():637630. PubMed ID: 33717186
    [No Abstract]   [Full Text] [Related]  

  • 6. Inducible Foxp3+ regulatory T-cell development by a commensal bacterium of the intestinal microbiota.
    Round JL; Mazmanian SK
    Proc Natl Acad Sci U S A; 2010 Jul; 107(27):12204-9. PubMed ID: 20566854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Memory/effector (CD45RB(lo)) CD4 T cells are controlled directly by IL-10 and cause IL-22-dependent intestinal pathology.
    Kamanaka M; Huber S; Zenewicz LA; Gagliani N; Rathinam C; O'Connor W; Wan YY; Nakae S; Iwakura Y; Hao L; Flavell RA
    J Exp Med; 2011 May; 208(5):1027-40. PubMed ID: 21518800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulatory T cells expressing interleukin 10 develop from Foxp3+ and Foxp3- precursor cells in the absence of interleukin 10.
    Maynard CL; Harrington LE; Janowski KM; Oliver JR; Zindl CL; Rudensky AY; Weaver CT
    Nat Immunol; 2007 Sep; 8(9):931-41. PubMed ID: 17694059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Type I interferons maintain Foxp3 expression and T-regulatory cell functions under inflammatory conditions in mice.
    Lee SE; Li X; Kim JC; Lee J; González-Navajas JM; Hong SH; Park IK; Rhee JH; Raz E
    Gastroenterology; 2012 Jul; 143(1):145-54. PubMed ID: 22475534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral tolerance induction with antigen conjugated to cholera toxin B subunit generates both Foxp3+CD25+ and Foxp3-CD25- CD4+ regulatory T cells.
    Sun JB; Raghavan S; Sjöling A; Lundin S; Holmgren J
    J Immunol; 2006 Dec; 177(11):7634-44. PubMed ID: 17114433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TNFRp55 controls regulatory T cell responses in Yersinia-induced reactive arthritis.
    Cargnelutti E; Arias JL; Valdez SR; Rabinovich GA; Di Genaro MS
    Immunol Cell Biol; 2013 Feb; 91(2):159-66. PubMed ID: 23207279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ablation of peroxiredoxin II attenuates experimental colitis by increasing FoxO1-induced Foxp3+ regulatory T cells.
    Won HY; Jang EJ; Lee K; Oh S; Kim HK; Woo HA; Kang SW; Yu DY; Rhee SG; Hwang ES
    J Immunol; 2013 Oct; 191(8):4029-37. PubMed ID: 24048895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD4+ Foxp3+ regulatory T cells suppress γδ T-cell effector functions in a model of T-cell-induced mucosal inflammation.
    Yurchenko E; Levings MK; Piccirillo CA
    Eur J Immunol; 2011 Dec; 41(12):3455-66. PubMed ID: 21956668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD44 expression positively correlates with Foxp3 expression and suppressive function of CD4+ Treg cells.
    Liu T; Soong L; Liu G; König R; Chopra AK
    Biol Direct; 2009 Oct; 4():40. PubMed ID: 19852824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammation-driven reprogramming of CD4+ Foxp3+ regulatory T cells into pathogenic Th1/Th17 T effectors is abrogated by mTOR inhibition in vivo.
    Yurchenko E; Shio MT; Huang TC; Da Silva Martins M; Szyf M; Levings MK; Olivier M; Piccirillo CA
    PLoS One; 2012; 7(4):e35572. PubMed ID: 22545118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A central role for induced regulatory T cells in tolerance induction in experimental colitis.
    Haribhai D; Lin W; Edwards B; Ziegelbauer J; Salzman NH; Carlson MR; Li SH; Simpson PM; Chatila TA; Williams CB
    J Immunol; 2009 Mar; 182(6):3461-8. PubMed ID: 19265124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contrasting roles for all-trans retinoic acid in TGF-beta-mediated induction of Foxp3 and Il10 genes in developing regulatory T cells.
    Maynard CL; Hatton RD; Helms WS; Oliver JR; Stephensen CB; Weaver CT
    J Exp Med; 2009 Feb; 206(2):343-57. PubMed ID: 19204112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD69 regulates type I IFN-induced tolerogenic signals to mucosal CD4 T cells that attenuate their colitogenic potential.
    Radulovic K; Manta C; Rossini V; Holzmann K; Kestler HA; Wegenka UM; Nakayama T; Niess JH
    J Immunol; 2012 Feb; 188(4):2001-13. PubMed ID: 22250092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-21 regulates experimental colitis by modulating the balance between Treg and Th17 cells.
    Fantini MC; Rizzo A; Fina D; Caruso R; Becker C; Neurath MF; Macdonald TT; Pallone F; Monteleone G
    Eur J Immunol; 2007 Nov; 37(11):3155-63. PubMed ID: 17918200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Type I IFNs regulate effector and regulatory T cell accumulation and anti-inflammatory cytokine production during T cell-mediated colitis.
    Kole A; He J; Rivollier A; Silveira DD; Kitamura K; Maloy KJ; Kelsall BL
    J Immunol; 2013 Sep; 191(5):2771-9. PubMed ID: 23913971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.